Is this product for human or veterinary use?

No. Aero Peptides materials are sold exclusively for in-vitro research and laboratory analytical use. They are not intended to diagnose, treat, cure, or prevent any disease, and are not approved for human or animal administration. By placing an order, you confirm that you are a qualified researcher and that the material will be used in accordance with all applicable institutional and jurisdictional regulations.

What does the Certificate of Analysis (COA) cover?

Each lot is independently tested for identity, purity, and mass using HPLC and mass spectrometry. The COA lists the lot number, test date, assay results, and the laboratory that performed the analysis. Public COA documents are being prepared. In the meantime, you can request a COA for your specific lot at /lab-results and we'll email it within 1 business day.

How is the product shipped and stored in transit?

Orders ship quickly after your order is placed, from the US. Lyophilized peptides are shipped with insulation appropriate to season; short-term ambient excursions during transit do not measurably affect potency. On receipt, store at -20°C in the sealed vial until reconstitution. Tracked shipping is included; we ship to all US states and most international destinations.

What does reconstitution look like in practice?

Most peptides are reconstituted with bacteriostatic water (BAC). The volume depends on the target working concentration. Use the Peptide Calculator at /reconstitution-calculator to compute volume, U-100 insulin syringe units, and doses per vial from peptide mass and target dose. Once reconstituted, store at 2-8°C and use within 30 days. Protect the vial from light during storage and handling.

Can I return or exchange a vial?

Because peptides are temperature-sensitive research materials, we cannot accept returns of opened or unsealed vials. If a shipment arrives damaged or the seal is broken on arrival, contact us within 7 days and we'll replace or refund. See the full returns policy at /returns for details.

Growth Hormone Support

CJC-1295 NO DAC (5mg) + IPA 5mg

Name: CJC-1295 NO DAC (5mg) + IPA (5mg)
SKU: aero-36
Price: 69.99 USD
Availability: InStock

ModGRF(1-29) + IPACJC + Ipamorelin BlendDual GHRH/GHRP Research StackModGRF(1-29) / Ipamorelin

A blended preparation pairing CJC-1295 without DAC (also known as Modified GRF(1-29), a 29-amino-acid growth-hormone-releasing-hormone analogue) with ipamorelin, a pentapeptide growth-hormone secretagogue that acts as a selective agonist at the ghrelin / GHS-R1a receptor. The two compounds engage distinct, complementary nodes of the somatotropic axis: GHRH-receptor stimulation at the anterior pituitary and ghrelin-receptor activation at both pituitary and hypothalamic sites. Classical work by Bowers and colleagues established that GHRH and GHRP-class secretagogues produce additive-to-synergistic effects on GH release in vivo, and subsequent preclinical work has extended this observation to long-acting GHRH analogues co-administered with selective ghrelin mimetics. Ipamorelin is distinguished within its class by selectivity: published characterisation reports GH release without meaningful elevation of ACTH, cortisol, prolactin, FSH, LH or TSH. Supplied as a research-grade blended preparation for in vitro and animal-model laboratory study of dual-pathway secretagogue pharmacology, receptor cross-talk, and pulsatility. For laboratory and research use only.

Dosage

5MG

$69.99

Peptide Calculator →

Quantity

Ships quickly after your order is placed

Damage protection

Secure checkout · 256-bit SSL

Research focus

How CJC-1295 NO DAC (5mg) + IPA is studied

Summary of contexts in which this compound appears in the preclinical literature. See cited studies for primary sources.

Areas of research interest

GHRH-receptor pharmacology
Ghrelin / GHS-R1a receptor signalling
Dual-pathway secretagogue synergy
Somatotropic-axis pulsatility models
Selective GH-release characterisation
Glucocorticoid-induced growth retardation models
Pituitary histomorphometry
Gastrointestinal motility research

Technical specifications

Compound & stability data

Compound Information

What is CJC-1295 NO DAC (5mg) + IPA (5mg)?

Blended research peptides (two constituents)

CJC-1295 (no DAC) / ModGRF(1-29)
CAS Number
863288-34-0
Molecular Weight
3367.96 g/mol
Sequence
YADAIFTQSYRKVLAQLSARKLLQDIMSR
Formula
C152H252N44O42
Ipamorelin
CAS Number
170851-70-4
Molecular Weight
711.86 g/mol
Sequence
Aib-His-D-2-Nal-D-Phe-Lys
Formula
C38H49N9O5

Storage & Stability

Handling requirements

Lyophilized (powder)
-20°C • long-term stable in sealed lyophilized form
Reconstituted
2-8°C • use within 30 days of reconstitution
Light
Protect from light during storage and reconstitution
Room temperature
Short-term tolerant during shipping; minimise extended exposure above 25°C

Dosing in the literature

Research dosing context

Observational summary of values reported in published research. Not a guide for human or animal use.

Reconstitution
Blended preparations are typically reconstituted in 1 mL bacteriostatic water per 5 mg vial, yielding a combined working concentration of ~5 mg/mL for each constituent in research preparations.
Published protocols
Preclinical studies of combined GHRH / GHRP administration (Fintini et al. 2006, Bowers et al. 1990) used SC injection routes in rodent models. Ipamorelin PK characterisation (Johansen et al. 1998) reported SC and IV administration in animal cohorts; no blended human clinical trial protocols have been published.
Half-life
~30 minutes for CJC-1295 without DAC (short-acting, no albumin binding); ~2 hours for ipamorelin in preclinical PK studies (Johansen et al. 1998).
Post-reconstitution stability
~28 days at 2–8 °C in BAC-water solution.

Half-life values from Johansen et al. 1998 (Xenobiotica, PMID 9879640) for ipamorelin and from published GHRH(1-29) PK literature. Reconstitution range based on general blended-peptide research conventions; no dedicated blended-preparation PK trial is cited on this file.

Sources & references

Peer-reviewed research

European Journal of Endocrinology

Ipamorelin, the first selective growth hormone secretagogue

Raun K, Hansen BS, Johansen NL, et al.

1998 · DOI: 10.1530/eje.0.1390552 · PMID: 9849822

Read on PubMed ↗

Xenobiotica

Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption

Johansen PB, Hansen KT, Andersen JV, et al.

1998 · DOI: 10.1080/004982598238976 · PMID: 9879640

Read on PubMed ↗

Growth Hormone & IGF Research

Growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced growth retardation

Andersen NB, Malmlöf K, Johansen PB, et al.

2001 · DOI: 10.1054/ghir.2001.0239 · PMID: 11735244

Read on PubMed ↗

Histology and Histopathology

Influence of chronic treatment with growth hormone secretagogue ipamorelin in the histomorphometry of male rat hypophysis

Jiménez-Reina L, Cañete R, de la Torre MJ, et al.

2002 · DOI: 10.14670/HH-17.707 · PMID: 12168778

Read on PubMed ↗

Endocrinology

Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog

Jetté L, Léger R, Thibaudeau K, et al.

2005 · DOI: 10.1210/en.2004-1286 · PMID: 15817669

Read on PubMed ↗

Neuroendocrinology

Effects of combined long-term treatment with a growth hormone-releasing hormone analogue and a growth hormone secretagogue in the growth hormone-releasing hormone knock out mouse

Fintini D, Alba M, Schally AV, et al.

2005 · DOI: 10.1159/000092520 · PMID: 16601359

Read on PubMed ↗

American Journal of Physiology - Endocrinology and Metabolism

Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse

Alba M, Fintini D, Sagazio A, et al.

2006 · DOI: 10.1152/ajpendo.00201.2006 · PMID: 16822960

Read on PubMed ↗

Journal of Clinical Endocrinology & Metabolism

Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults

Teichman SL, Neale A, Lawrence B, et al.

2006 · DOI: 10.1210/jc.2005-1536 · PMID: 16352683

Read on PubMed ↗

Journal of Clinical Endocrinology & Metabolism

Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone

Bowers CY, Reynolds GA, Durham D, et al.

1990 · DOI: 10.1210/jcem-70-4-975 · PMID: 2108187

Read on PubMed ↗

Journal of Pharmacology and Experimental Therapeutics

Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus

Venkova K, Mann W, Nelson R, et al.

2009 · DOI: 10.1124/jpet.108.149211 · PMID: 19289567

Read on PubMed ↗

International Journal of Colorectal Disease

Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients

Beck DE, Sweeney WB, McCarter MD, et al.

2014 · DOI: 10.1007/s00384-014-2030-8 · PMID: 25331030

Read on PubMed ↗

11 peer-reviewed references listed. Citations verified against NCBI PubMed records. For research and educational reference only — does not constitute medical advice.

Researcher FAQ

Common questions

Is this product for human or veterinary use?
No. Aero Peptides materials are sold exclusively for in-vitro research and laboratory analytical use. They are not intended to diagnose, treat, cure, or prevent any disease, and are not approved for human or animal administration.
By placing an order, you confirm that you are a qualified researcher and that the material will be used in accordance with all applicable institutional and jurisdictional regulations.
What does the Certificate of Analysis (COA) cover?
Each lot is independently tested for identity, purity, and mass using HPLC and mass spectrometry. The COA lists the lot number, test date, assay results, and the laboratory that performed the analysis.
Public COA documents are being prepared. In the meantime, you can request a COA for your specific lot and we’ll email it within 1 business day.
How is the product shipped and stored in transit?
Orders ship quickly after your order is placed, from the US. Lyophilized peptides are shipped with insulation appropriate to season; short-term ambient excursions during transit do not measurably affect potency.
On receipt, store at −20°C in the sealed vial until reconstitution. See the handling matrix for full storage parameters. Tracked shipping is included; we ship to all US states and most international destinations.
What does reconstitution look like in practice?
Most peptides are reconstituted with bacteriostatic water (BAC). The volume depends on the target working concentration. Use our Peptide Calculator to compute volume, U-100 insulin syringe units, and doses per vial from peptide mass and target dose.
Once reconstituted, store at 2–8°C and use within 30 days. Protect the vial from light during storage and handling.
Can I return or exchange a vial?
Because peptides are temperature-sensitive research materials, we cannot accept returns of opened or unsealed vials. If a shipment arrives damaged or the seal is broken on arrival, contact us within 7 days and we’ll replace or refund.
See our full returns policy for details.

Don’t see your question? Contact our research team — we typically reply within one business day.

In the same category

Researchers also studied

IGF1-LR3 1mg

$69.99

Growth Hormone Support

View

KISSPEPTIN-10 10mg

$39.99

Growth Hormone Support

View

Tesamorelin 10mg

$64.99

Growth Hormone Support

View

CJC-1295 NO DAC 10mg

$69.99

Growth Hormone Support

View

Frequently paired

Often ordered together

Reconstitution BAC 10ml

$5.99

Reconstitution

View

MOTS-C (10mg-20mg)

From$39.99

Cellular Health & Longevity2 dosages

View

⚠ Important research notice

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.

CJC-1295 NO DAC (5mg) + IPA 5mg

ModGRF(1-29) + IPACJC + Ipamorelin BlendDual GHRH/GHRP Research StackModGRF(1-29) / Ipamorelin